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lINTRODUCTION
Diminished orthostatic and exercise tolerance are common sequelae
(1-3)
of relatively short periods of weightlessness. Similar changes
occur as a result of prolonged bedrest. Prior studies in this labora-
tory have delineated in detail many of the physiologic and metabolic
changes that occur when bedrest is used as an analog of weightlessness.
-During the initial 24 - 48 hours of-bedrest a large saluresis with
accompanying water diuresis occurs as a result of a decrease in aldo-
(4)
sterone production. This saluresis and diuresis persists to a
lesser extent throughout bedrest. The result is a decrease in plasma
volume and extracellular fluid volume. The-magnitude of the decrease
is virtually as great after 24 hours as after four weeks of bedrest.(4 )
There is also an apparent decrease in body muscle mass which is revealed
by significant losses of nitrogen and potassium and by a decrease in
total body water without a corresponding decrease in body weight. 4)
Following bedrest of intervals as short as two weeks, distinct
hemodynamic alterations are seen when volunteers are subjected to
orthostatic and exercise testing. During 700 tilt testing, stroke
volume drops to significantly lower levels than prior to bedrest and
in spite of significantly higher heart rates, cardiac output falls
(5,6)
to significantly lower levels. These changes are accompanied
by an incidence of Pyncne or presyncope that is about 20% higher
after four weeks of bedresto(4 ) Orthostatic tolerance returns to
pre-bedrest levels by 2-7 days after re-ambulation in most subjects.
This return of orthostatic tolerance appears to occur as a result of
restoration of plasma and extracellular fluid volume to pre-bedrest
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levels within a week of re-ambulation. The latter is brought about
by a large increase in aldosterone production during the first days
of re-ambulation and the associated retention of sodium and water.(4)
Decreased exercise tolerance resulting from bedrest is clearly
measurable after only two weeks of bedrest. When subjects were tested
by supine bicycle ergometry, stroke volume did not rise significantly
above resting values at 50 Watts exercise whereas a significant rise
was seen before bedrest. Heart rate showed highly significant increases
after bedrest, but this was insufficient to raise cardiac output to
levels achieved prior to bedrest (5,6) Furthermore, derived maximal
oxygen uptake was found to decrease after four weeks and subsequently
after two weeks of bedrest.( 4' ) This change did not return to pre-
bedrest levels in conjunction with plasma volume restoration. In
contrast, it required two weeks of ambulation for restoration to pre-
bedrest levels. In fact, sixteen of twenty-four subjects who were at
bedrest for four weeks had not achieved pre-bedrest levels at the end
of two weeks of re-ambulation.(4 Similar decreases in maximal oxygen
uptake resulting from bedrest have been noted by Saltin, et alo (8)
ine above findings point to differences in the etiologies of
orthostatic and exercise intolerance after bedrest, and by inference,
after weightlessness. Whereas the decrease in orthostatic tolerance
appears largely related to diminished vascular filling and inadequate
venous return, the more prolonged decrease in exercise tolerance and
the findings noted suggest. that bedrest also decreases myocardial
function.
However, the relationship between circulating blood volume and
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physical fitness is complex. Danzinger and Cumming( 9 ) demonstrated
decreased maximal oxygen uptake in normal subjects made hypovolemic
by chlorthiazide administration, and found this effect to be revers-
ible with intravenous dextran. Contradictory evidence is given by
Saltin( 1 0 ) tho indicated that no change in maximal oxygen uptake or
cardiac output was effected by thermal dehydration in a group of normal
subjects. Holmgren, et al reported a strong correlation between
work capacity, level of physical training, and total blood volume.
The same correlation had previously been suggested by Kjellbeig.( 2 )
A more recent and contrary position is held by Robinson, et al(3)
whose carefully conducted study could demonstrate no increase in
maximal oxygen consumption or cardiac output in six normal men as a
result of intravenous whole blood infusion during maximal upright
exercise. At heart rates existent during maximal or near maximal
exercise the diastolic filling period of the heart is decreased.(14 )
Thus, the influence of vascular filling is minimal at these heart
rates, maximal oxygen uptake and cardiac output being limited primarily
by the inotrophic state of the myocardium and the completeness of
systolic emptying.
To summarize, even though supine cardiac output is known to be
greater than upright cardiac output at rest and during submaximal
exercise,( 1 5 ) at maximal work loads, the main determinant of perfor-
mance is the inotrophic state of the heart ( 3) Similarly, it may
be reasoned that the hypovolemia of bedrest (and weightlessness) is
not the cause of the concomitant decrease in maximal exercise
capability. Consistent with this view, Stephens, et al( 1 6 ) were unable to
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prevent bedrest-induced decreases in maximum oxygen consumption by
application of lower body negative pressure, despite full restoration
of blood volume by that device, again suggesting the possibility of
diminished myocardial function after bedrest.
The present study was undertaken in an attempt to approach more
directly the question of whether alterations in myocardial contractility
are induced by bedrest (or weightlessness). The standard measurements
(17)
of contractility require left ventricular catheterization, and proof
of bedrest alterations would require such studies to be performed on
two occasions. For ethical reasons left ventricular catheterization
of normal volunteers was excluded from consideration. Instead, three
non-invasive methods were chosen. These were: apexcardiography (ACG),
systolic time intervals (STI), and echocardiography. The validity of
the three methods of determining myocardial contractility used in the
present study rest upon evidence of correlation with internally derived
indices of contractility such as ejection fraction, Vm, maximum dP/dt,
left ventricular end-diastolic volume and pressure, stroke-work index, etc.
APEXCARDIOGRAPHY
In recent years a number of papers have been published relating
the ACG to the hemodynamic status of the heart. Findings in the ACG
assist in identifying events in the phonocardiogram.(18 23) Measurement
of the ACG "a" wave is a useful estimate ot left ventricular end-diastolic
pressure and mean left atrial pressure,( 2 4 2 5 ) and the presence of con-
gestive failure(26 2 9 ) Qualitative trends in the ACG are manifested
by such entities as left ventricular hypertrophy,( 3 0 ) myocardial
assynergy,(31-33) idiopathic hypertrophic subaortic stenosis,(3 )
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(35-37) (38-40)
myocardial infarction, left atrial disease, and right
(41-42) (43-45)
ventricular hypertrophy. Study of the rapid filling wave
is promising as a non-invasive means of measuring left ventricular
compliance. Few studies have been published which define the ACG in
terms of absolute displacement.(33' 9 ' 4 6) This is largely because of
the difficulty in calibrating transducers to quantify displacement of the
ACG from some theoretical baseline, as well as difficulty in defining
what is normal by that method. These problems have been obviated by
quantitating the ACG according to ratios of related peaks in the tracing,
and by measuring time intervals. Because of the close resemblance between
the ACG and the left ventricular pressure curve, and between the first
derivative of the ACG and the first derivative of that pressure, study
of dA/dt (ACG first derivative) has attracted interest since 1951. (4 7 '4 8 )
The interval from the onset of ventricular depolarization to peak dA/dt
(49)(R-dA/dt) was shown by Reale to correlate exactly with the interval
from the onset of ventricular depolarization to the peak dP/dt (R-dP/dt).
This latter is known to be an excellent indicator of cardiac contractility,
(50)
unaffected by changes in preload and afterload. Studies in this
laboratory have shown that the value of R-dA/dt can differentiate among
normal, hyperdynamic, and failing hearts. C-ood correlation was found
in 23 patients between R-dA/dt and catheterization indices of left ventri-
cular function, such as ejection fraction, Vmax, peak dP/dt, and left
ventricular end-diastolic pressure and volume.
SYSTOLIC TIME INTERVALS
Of the methods used in the present study the STI have probably been
the most extensively studied.(52
- 5 9 ) Over a decade ago, Weissler, et al
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showed that the left ventricular ejection time (LVET) was fairly
linearly related to stroke volume, and this relationship could be
used to separate normal individuals from those with cardiac failure.(52)
More recently the pre-ejection period (PEP), which can be subdivided
into the Q-S1 (onset of the QRS to onset of the first heart sound) and
the isovolumic contraction time (ICT), was found to reflect changes in
internally measured ICT.( 5 4 '5 9 '6 0 ) The ratio PEP/LVET has been repeatedly
correlated with ejection fraction as well as with contractile element
velocity at peak isometric stress(615) and with the Frank-Levinson
contractility indices.(6 36 4 ) In terms of functional significance, the
STI have been shown to undergo characteristic alterations in acute
myocardial infarction,( 6 5 ) and in cardiac decompensation from a variety
of causes.(52 ,5 4 ,56,6 1 - 6 3 ,65 -6 7) The STI are predictably affected by
the positive inotropic forces such as exercise(5868) digitalis,( 5 5 )
and adrenergic stimulation.(6 6 '69 '70) While preload and afterload
effects upon the STI are rather uncertain, Stafford, et al(71) found
that either passive 900 head-up tilt or the application of tourniquets
will increase PEP/LVET, thus suggesting that the left ventricular end-
diastolic volume may be a determining variable. Ahmed(66 noes that
an improved correlation with ejection fraction and V is achieved
max
only when patients with valvular disease, shunts, and pulmonary disease
are excluded from consideration.
ECHOCARDIOGRAPHY
The use of pulsed reflected ultrasound to examine the heart,
echocardiography, is the most recent major external biosensor technique
to be added to the cardiologic armamentarium. Early experience with
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echocardiography quickly led to its present unique role in diagnosing
pericardial and mitral valvular disorders.(774) The facility with
which the posterior wall of the heart and its mean velocity in systole
(PWV) have been determined by echocardiography has led to publication
of data showing good correspondence of the PWV with velocity of
circumferential fiber shortening.(7 '76) Kraunz and Kennedy( 75 )
found that both maximal posterior wall velocity and PWV were consis-
tently increased by the positive inotropic effect of exercise, and
were roughly correlated with heart rate. Studies by Rowyer, et al(
7 7 )
(78)
and by Rushmer, et al( 7 8 ) have indicated a close correlation between
the posterior wall echogram and standard left ventricular volume curves.
The relative effects of preload and afterload on, and the relationship
of cardiac contractility to the posterior wall echogram have not as yet
been firmly established. Further, the repeatability of the PWV needs
more substantiation than is presently available in the literature.
METHODS
Subjects for the study were healthy male volunteers, aged 20-29.
They weighed 139.6 to 191.1 lbs-(mean 161.2) and were 65 to 75 in-
tall (mean 69.3). Upon admission to the Metabolic Ward, all subjects
were given thorough medical evaluation and placed on a metabolically
balanced diet, with a normal, fixed intake of sodium, described
elsewhere. Following an initial equilibration period of 7-10 days,
a two week control period (C) preceded 28 days of absolute horizontal
bedrest (B), which in turn was followed by a two week recovery phase (R).
In general, studies were performed weekly during the control period,
Recruited from the Federal Correctional Institution, Lompoc, Calif.
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at the end of bedrest, and at the end of each subsequent week of
recovery. Studies in some subjects were done at weekly intervals
throughout all phases. In addition to study of patients undergoing
four weeks of bedrest, a number of patients were studied under identical
conditions while undergoing only two weeks of bedrest. These studies
were performed to enable definition of early bedrest changes.
All procedures were performed -about 8 A.M. in the Cardiac Catheter-
ization Laboratory. The subjects were transported to the laboratory
by guerny in the supine position, and were in the post-absorptive state.
Apexcardiography
With the subject rotated anywhere from 30° to 50° toward the left
lateral decubitus position in an angiography cradle, the cardiac apex
was located by fingertip palpation. A piezo-electric microphone
(Electronics for Medicine Model PS-1B) was employed connected to the
multiple band phono amplifier of a multichannel photographic recorder.
The amplifier range was set at 1 to 50 Hz. The microphone was held in
its interspace by a circumferential elastic Velcro(R) strap. The first
derivative of the apexcardiogrom, dA/dt, was obtained by means of a
resistance-capacitance network with a flat response in the range of
0 to 75 Hz. Tracings were made at paper speeds of 100 mm/sec with
0.1 sec vertical time lines. An electrocardiogram was recorded
simultaneously, from a iead configuration which give a distinct Q-wave,
and this same configuration was repeated for subsequent studies in
each individual. The R-R interval preceding each cycle, and the
interval R-dA/dt ("R" in this case meaning the onset of the QRS),
Electronics for Medicine DR-16
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were measured by averaging the values obtained from 12 cardiac cycles
during normal respiration. A correction for the effect of heart rate
was applied to the interval R-dA/dt by dividing it by the square root
of the R-R interval (see Results). Prior to final analysis of results,
the change in R-dA/dt/ FR-R after four weeks of bedrest in;
subjects receiving 9-alpha-fluorohydrocortisone was compared with the
change seen in untreated volunteers. There was no significant differ-
ence and all data was, therefore, treated as a single homogeneous pool.
Systolic Time Intervals
The STI of the left ventricle were obtained by simultaneous
recordings of the carotid pulse, phonocardiogram, and electrocardiogram.
When possible, the STI were recorded simultaneously with the ACG and
dA/dt. A piezo-electric microphone (Electronics for Medicine PS-13)
with a 4 mm diameter cylindrical pickup was used with an amplifier
channel of the multipurpose photographic system to obtain the carotid
pulse wave form by placing the microphone over a carotid artery below
the carotid sinus. A similar microphone with a diaphram-type pickup
w-s used to record heart sounds in the 100 to 500 Hz range from -
position along the left sternal border which gave maximum resolution
of the two components of the second heart sound. The period of electro-
mechanical systole, from the onset of the QRS to the aortic component
of the second heart sound (Q-S2) was determined along with the LVET,
measured from the sharp upstroke of the carotid wave to the incisura.
PEP was determined by the formula, PEP = Q-S2 - LVET. Final values
were obtained by meaning the results of twelve cardiac cycles during
normal respiration. The ratio PEP/LVET were determined for all results.
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The heart rate corrected indices of the STI, the Q-S2I, LVETI and
PEPI were calculated by the method of Weissler.( 7 9 ) As in the case
of R-dA/dt/ wR-R, the changes in the ratio PEP/LVET of the
subjects of the 9-alpha-fluorohydrocortisone treated group and the
untreated group were determined at the end of the fourth week of
bedrest. No significant difference was found and the data were pooled.
Echocardiography
With the subject in the supine position, ultrasonic determination
of left ventricular wall motion was made using the Ekoline 20 Ultra-
sonoscope (Smith, Kline, and French Instrument Co.). This employs a
2.25 megacycle 3/4 in. transducer with a 10 cm focus which transmits
1 isec ultrasonic impulses at a rate of 2 00/sec. The intracardiac
structures were scanned in a sequential and repeatable foremat in an
attempt to identify a specific echo window for recording posterior
left ventricular wall motion. The method consists of placing the
transducer in the fourth or fifth left intercostal space at the left
sternal border. The transducer is angulat2d in a right superio-medial
direction until characteristic echos of the ascending anrta a-e
recognized in B mode scanning. The transducer is then directed infero-
laterally until the mitral annulus and subsequently the mitral valve
echoes are clearly identified. This motion of the transducer is con-
tinued until the mitral valve echo disappears and characteristic echo
recordings of the cords and subsequently the papillary muscle are
identified. The transducer is then ideally beamed at the area underneath
the posterior leaflet of the mitral valve superior to the papillary
muscle. The echo window is clearly and rapidly identified by an
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experienced echocardiographer, and in most cases, high fidelity
recordings of the posterior wall motion are recorded using analog
gating techniques. Calibrations were made by moving the gate over
the pure echo signal of a plexiglass block such that 1 cm of gate
motion produced a 5 cm displacement of the recorded signal. Records
were made by means of an Electronics for Medicine photographic recorder
at paper speeds of 100 mm/sec. EKG was recorded simultaneously.
The magnitude of posterior wall excursion (PWE) was determined
by measurement of the amplitude of the systolic excursion of the
recorded posterior wall curve from baseline or end-diastolic position.
The mean velocity of excursion (PWV) was found by measuring the angle
that the slope of the line extending from the onset of systole to
(75)the peak of systolic movement makes with the baseline. The tangent
of this angle divided by the calibration factor and multiplied by 100
gave the PWV in cm/sec. High fidelity recordings were meaned from
at least six cardiac cycles to derive the values. Since both PWE
and PWV are related to myocardial contractile state, their product
(PWV x PWE) was evaluated as an additional index.
In order to document the value of these measurements as indicators
of the state of left ventricular function, they were compared with
standard cardiac catheterization indices in 21 patients. These results
as well as those of bedrest subjects will be presented.
Statistical Methods
All results were analyzed for statistical significance by the paired
Student's "t" test. Standard techniques were used in determining corre-
(80)lation coefficients and standard errors. Significance was presumed
to exist for all values of P <.05.
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RESULTS
Apexcardiography
Table 1 contains the results of measurement of R-R interval
(heart rate), R-dA/dt, and values for R-dA/dt/ERR for all subjects
at the end of each indicated week of study. Figure 1 illustrates the
measurement of R-dA/dt. In total, sixteen subjects were studied
before and after four weeks of bedrest, and eight subjects before
and after two weeks of bedrest. In each subject the results of the
Control Week 2 (baseline) R-dA/dt measurements were correlated with
R-R intervals, systolic and diastolic blood pressures, and plasma
volumes existent at the time of the measurements (Table 2). Of these,
only heart rate (R-R interval) was found to correlate with R-dA/dt
(r = 0.525, P <0.01). The regression line for the relationship
between R-dA/dt (sec) and R-R interval (sec) is shown in Figure 2.
This relationship is expressed for the 24 subjects studied by the
formula: R-dA/dt = 0.629 (R-R) + 0.0266. In the analysis of bedrest
effects on R-dA/dt it was necessary to correct for alterations in
basal heart rate induced by bedrest and the resultant effects on
R-dA/dt. This was accomplished by two separate approaches.
Firstly, all heart rates fell within the range of 40-12 0/minute
(R-R interval 0.50 - 1.50 sec).' In this range it is possible to
correct all values for R-dA/dt to a value which would be existent
at a heart rate of 60 (R-R = 1.0 sec) by dividing R-dA/dt by TR-R.
This is possible because the relationship between JTRR's for varying
R-R intervals is essentially linear in the stated range. The results
of this correction for heart rate (R-dA/dt/xPR-R) are shown in Table 1
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with the basic data. Tables 3-7 show the paired analysis of changes
in heart rate, R-dA/dt, and R-dA/dt/ NrR-R at the end of one week of
bedrest (Bl), two weeks of bedrest (B2), four weeks of bedrest (B4),
and after two and three weeks of ambulant recovery (R2 and R3). The
pertinent changes in R-dA/dt/ NfR-R are summarized in Table 8, and
presented graphically in Figure 3. It is apparent that significant
prolongation of this measurement occurs by the end of the second week
of bedrest (P <0.05) and persists beyond the end of the second recovery
week (P <0.02). Beyond pure statistical results, this table also shows
that by even one week of bedrest, four of six subjects have developed
a prolonged R-dA/dt/FR-RR. Similar evaluation shows 14 of 16 subjects
(88%) with this alteration at the end of four weeks. After three
weeks of recovery, only slightly more than one-half of subjects have
returned to their pre-bedrest status.
Since the correction of the data to a common heart rate of
60/minute might be considered arbitrary, the regression equation
(vide supra) relating R-R interval to R-dA/dt for this group of
subjects was utilized to determine a predicted R-dA/dt for each
subject on each day of study based upon his heart rate at the time
of measurement. The predicted values were then compared with their
paired experimentally measured values on each day of study. The
results are shown in Tabl' 9. Using this method of aaalysis, a
prolongation in R-dA/dt beyond that due to a change in heart rate
alone is seen at the end of one week of bedrest, becoming significant
after two weeks (P <0.05) and remaining significantly prolonged even
at the end of three weeks of ambulant recovery (P <0.05).
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No correlation between R-dA/dt and plasma volume was noted in
baseline measurements (Table 2). However, bedrest is well known to
lower plasma volume. The magnitude of these decreases in plasma volume
are unlikely to alter left ventricular pre-load in the supine subject.
However, this possibility was analyzed. Tables 10-13 show the comparison
of plasma volumes for each subject studied by apexcardiography at the
end of-bedrest-weeks 1,2 and 4 and at the end of recovery week two with
paired control values. The mean values for each group are shown in
Table 14 and illustrated in Figure 4. The decrease in plasma volume
becomes statistically significant at the end of two weeks of bedrest
(B2, P <0.005), and remains significant after four weeks (B4, <0.05)
in spite of the effects of plasma volume expansion by 9-alpha-fluoro-
hydrocortisone in four subjects. After two weeks of ambulant recovery
plasma volume has returned to levels equivalent to those existent
prior to bedrest.
The fact that the group changes in R-dA/dt/wrR-R and plasma
volume do not correspond, at least during the recovery period, again
suggests an independent change. To insure that no relationships
existed, each individual's change in plasma volume was correlated
with his change in R-dA/dt/ JR-R-at the end of first, second, and
fourth weeks of bedrest, and at the end of recovery week two
(Tables 15-18). In no case was there any -orrel!tior.
Systolic Time Intervals
Table 18 summarizes the systolic time interval data on each day
of study for ten subjects who underwent four weeks of bedrest and ten
subjects who underwent two weeks of bedrest. The actual measurements
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of R-R interval (heart rate), Q-S2 interval (interval between onset
of the QRS complex of the EKG and the onset of the aortic second
heart sound), PEP (pre-ejection period), LVET (left ventricular
ejection time), and the ratio PEP/LVET are given. Figure 1 illustrates
the determination of these intervals. The corresponding values,
corrected for heart rate, of O-S2I, LVETI and PEPI are also tabulated.
Because of the small number of subjects in the present study, Weissler's
(79)
regression equations were utilized for the heart rate corrections.
For the male, these are: Q-S2I = 2.1 (HR) + Q-S2
PEPI = 0.4 (HR) + PEP
LVETI = 1.7 (HR) + LVET
The ratio PEP/LVET encompasses changes in both PEP and LVET and
appears to be a sensitive indicator or left ventricular function.
Prior studies have shown it to be relatively uninfluenced by heart
rate.' In order to re-evaluate this question and to evaluate the
potential effects of blood pressure (after load) and plasma volume
(pre-load) alterations in the subjects of the current study, the
baseline values of control Week 2 for PEP/LVET were correlated with
existent heart rate (R-R interval), systolic and diastolic blood
pressure, and plasma volume (Table 20). There was no correlation
with any of these parameters.
Tables 21-25 tabulate the paired comparisons of R-R interval,
Q-S2 I, LVETI, PEPI and PEP/LVET of the baseline values with bedrest
weeks 1,2 and 4, and recovery weeks 2 and 3. No statistically signif-
icant and consistent pattern of change is seen in PEPI, LVETI, or
Q-S2 I. The mean changes are depicted in Figure 5. The variable
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statistical results may be the result of the small sample and the
fact that the same subjects are not represented at each study period.
The results for PEP/LVET are perhaps more meaningful. As shown
in Table 26, this ratio is increased over corresponding control values
at all bedrest and recovery intervals. This increase is statistically
significant at the end of bedrest week one (P <0.0025), and week four
(P <0.02), and at the end of recovery week three (P <0.025). At the
end of bedrest week two and recovery week two, statistical signifi-
cance is approached, but not achieved (P <0.1). At all intervals,
over 70% of subjects show an increase in PEP/LVET after being
subjected to bedrest. The changes in PEP/LVET are illustrated
graphically in Figure 6.
Tables 27-30 compare the plasma volumes of subjects on whom STI
measurements were made at each study interval with their matched
control plasma volumes. Results are summarized in Table 31 and
presented graphically in Figure 7. The failure to show a statistically
significant decrease in plasma volume at the end of four weeks of
bedrest results from the fact that three of the ten subjects received
9-alpha-fluorohydrocortisone during the last week of bedrest.
Individual changes in PEP/LVET and plasma volume at each point of
the study are correlated in Tables 32-35. It is apparent that the
alterations seen in PEP/LVET were not influenced by the changes in
plasma volume induced by bedrest.
Echocardiography
Table 36 lists the diagnoses of the 21 patients in whom echo-
cardiographic studies were correlated with results obtained at left
ventricular catheterization. Fifteen intravascularly-derived
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measurements of left ventricular function were correlated with the
three echocardiographic parameters. Of the former, ejection fraction
(EF), R-dP/dt (the time interval from the onset of the QRS to the
peak velocity of left ventricular pressure rise), ICT (isovolumic
contraction time - the interval from the onset of the QRS to the
beginning of left ventricular ejection), and Vma
x
are most associated
with the intrinsic state of the heart or cardiac contractility; the
remaining indices are perhaps more reflective of myocardial performance.
Of all of these, ejection fraction is generally regarded as the best
single index of overall ventricular function. The results of all
measurements are shown in Table 37,
Echocardiographic correlations with the various indices and the
significance of the correlations are given in Table 38. Quite apparent
is that all three echogram indices correlated rather well with ejection
fraction. PWE showed additional sssociations with S.Vo (angio) (stroke
volume by angiographic methods), LVET and ICT. When data are grouped
according to the presence or absence of coronary artery disease
(Table 39), the correlations with ejection fraction become polarized;
extremely significant R values are obtained for the non-coronary group,
while those of the coronary group lose significance altogether. These
results with the coronary artery disease group are not unexpected.
Cineangiography very often shows such patients to manifest ventricular
akinesia and dyskinesia. The posterior wall echogram may in these
cases have characteristics not at all representative of the myocardium
as a whole.
On the basis of the promise offered by the above results, sequential
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echocardiograms were obtained in seven normal subjects undergoing
four weeks of bedrest, and three undergoing two weeks of bedrest.
Results of measurement of PWE and PWV are shown in Tables 40 and 41.
No attempt has been made to analyze this data statistically as it is
so grossly variable as to preclude any possibility of significance
testing.
DISCUSSION
The purpose of the present study was to determine whether or not
bedrest, and by inference, weightlessness, decreases myocardial
function. The latter possibility was suggested by the apparent
prolongation of decreased exercise tolerance (as measured by maximal
oxygen uptake) beyond the return of orthostatic tolerance after
bedrest. It was further suggested by the decrease in ability to
increase stroke and cardiac output during exercise after bedrest to
levels seen prior to bedrest. Answers to this question could be
quickly obtained by measurement of left ventricular function before
and after bedrest by standard left heart catheterization techniques.
Hovev.r, for ethical and moral ieasons the conduct of such studies on
normal volunteers is not possible. Further, these methods could tfot
be utilized on astronauts before and.after space flight, so no
comparisons between limited space flight and more extensive ground
based studies could be made. For these reasons it was necessary to
utilize non-invasive techniques to measure myocardial function in
the present study.
As noted previously quantitative apexcardiography, systolic time
interval measurements, and echocardiography have each been established
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.to be reliable means of determining the state of myocardial function
non-invasively. In the clinical situation where one is comparing
the results of measurements from diseased myocard-ums with those
from normal hearts, the differences are readily apparent. However,
at the outset of the present study it was not possible to predict
whether these methods would prove sufficiently sensitive to detect
relatively subtle changes in the myocardial function of normal
individuals. Had the study results been negative, it would not
have been possible to declare the absence of diminished ventricular
function, since negative results could have resulted from method
insensitivity. In fact, the echocardiographic results illustrate
this point. In the clinical subjects with diffuse myocardial disease,
results of measurement PWE and PWV showed good correlation with
ventricular function. In the bedrest subjects with normal heart size,
no reproducible individual pattern of results was obtainable. The
obvious reason for this problem relates to the inability to exactly
pin-point the same myocardial echo window on each occasion. While
this problem may not be insurmountable, it will require finite
technical study. Changes in heart size, such as may occur as a
result of plasma volume decreases, minor changes in body position
and the like can result in an altered echo window no matter how
carefully structures -are identified.
In contrast to echocardiography, measurement of the interval
R-dA/dt and measurement of systolic time intervals are not dependent
upon isolating and reproducing a small area of myocardium for repeated
evaluation. These measurements, which are more related to velocity
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and duration of total left ventricular contraction, appear more well
suited for longitudinal or sequential studies such as the present one.
The planned simultaneous use of both methods has the distinct
advantage of providing confirmatory evidence of alteration. In
addition, technical problems may be encountered with either method
with resultant loss of data. In some cases no adequate apexcardio-
gram can be obtained due to a muscular chest wall or increased
anterior-to-posterior diameter of the chest. Further, shattering
of the dA/dt trace occasionally makes interpretation difficult. In
normal individuals it is unusual to be unable to obtain the recordings
necessary to determine STI's. The prime problem here is in obtaining
a well-defined carotid pulse trace.
In the evaluation of the results of the current study, a number
of factors which are known to have an effect on ventricular function
were considered. These included: heart rate; pre-load; after-load;
and inotrophic state. Heart rate is known to influence STI's except
the ratio PEP/LVET and appropriate corrections were made.( 7 9 ) Our
results confirm the lack of correlation between PEP/LVET and heart
rate. In contrast, a definite correlation between heart rate and
the interval R-dA/dt has been demonstrated. However, the changes
seen as a result of bedrest have been clearly shown to be independent
of changes in heart rate brought about by bedrest.
In the present study, all measurements were made in the supine
position, and it was unlikely that the alterations in plasma volume that
occurred in the volunteers studied would affect pre-load. Confirmation
of a lack of effect was clearly shown by the failure of baseline
-21-
R-dA/dt/ .R-R and PEP/LVET measurements to correlate with baseline
plasma volume values. Further, when changes in plasma volume at the
various points of study were compared with simultaneous changes in the
above measurements, no correlation was found. The fact that prolon-
gation in R-dA/dt/,fR-R and PEP/LVET was not prevented in those
subjects whose bedrest induced plasma volume decrease was reversed
by treatment with 9-alpha-fluorohydrocortisone. also points to the
lack of relationship between these parameters and plasma volume change.
In addition, our prior studies have clearly shown plasma volume to
(4)
return to pre-bedrest levels by one week of ambulant recovery.
In contrast, R-dA/dt/ NR-R and PEP/LVET require 2-3 weeks or longer
for restoration, thus corresponding to the previously noted changes
(4)in maximal oxygen uptake.
There was also no correlation between systolic or diastolic
blood pressure and PEP/LVET or R-dA/dt/ JR-R. Even prior to demon-
stration of this fact, alterations in after-load were not considered
a problem. This was true because bedrest produces no significant
or consistent alterations in either resting or exercise blood pressure
(4-6)
or peripheral vascular resistance.
Having demonstrated that bedrest induced alterations in heart
rate, plasma volume (pre-load), and blood pressure (after-load) are
not responsible for the prolongations seen in PEP/LVET and R-dA/dt/ 'R-R,
the ultimate conclusion is obvious. The only remaining factor which
could influence these measurements is a decrease in the inotrophic
state of the myocardium.
-22-
CONCLUSION
The present study, utilizing quantitative apexcardiography
and measurement of systolic time intervals has demonstrated that
bedrest causes a detrimental alteration in the contractile state
of the myocardium of healthy volunteers. While these changes have
been demonstrated in resting basal subjects, they account for the
decreases in maximal oxygen uptake and failure to adequately augment
stroke volume and cardiac output during exercise after bedrest.
The prolonged nature of this change in inotrophy also accounts for
the dichotomy between the rapid return of post-recumbency orthostatic
tolerance and the slow return of post-recumbency exercise tolerance.
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TABLE 1
COMPOSITE APEX CARDIOGRAPHY DATA
Week of Study
C2
B4
C2
B4
C2
B4
C2
B4
C2
B4
R2
R3
C2
B4
R2
R3
C2
B4
R2
R3
C2
B4
R2
R3
C2
B4
R2
R3
C2
B4
R2
R3
R-R
.93
.80
1.01
.66
.72
.60
1.21
.88
.92
.76
.65
1.10
.94
,64
.82
.78
.76
o81
1.11
.76
1.09
86
.82
-1.02
.94
.76
.75
.83
,58
,.61
.65
.65
R-dA/dtSubject
HT
CT
GP
R-dA/dt
fRR
.060
.070
.062
.078
.080
.075
.080
.092
RR
.080
.085
.080
.080
.073
.110
.073
.085
DJ
.125
.135
.120
.120
.130
.155
.149
.125
CC
.105
.097
.110
.095
· 108
.121
.107
.108
JA
WR
.070
.075
.077
.070
.085
.103
.097
.101
.100
..091
o 100
.080
JW
.080
.083
.073
.080
.083
.111
.107
.100
.102
102
.116
.087
.048
.085
.055
.050
.063
· 104
.068
.062
TABLE 1
COMPOSITE APEX CARDIOGRAPHY DATA
Subject Week of Study R-R R-dA/dt R-dA/dt
SRR
JS C 2 .78 .080 .091
B 4 .74 .093 .109
R 2 .73 .096 .112
R 3 .72 .072 .085
BL C 2 1.13 .097 .091
B 1 1.16 .107 .100
B 2 1.06 .099 .096
B 4 1.03 .106 .105
R 2 1.01 .088 .088
R 3 1.06 .101 ..09B
RC C 2 1.07 .100 .099
B 1 .71 .097 .115
B 2 .63 .095 .120
B 4 .81 .120 .133
R 2 .60 .100 .129
R 3 .98 .100 .101
DY C 2 1.20 .106 .096
B 2 1.23 .136 .123
B 4 1.05 .121 .118
R 2 .92 .118 .123
R 3 .93 .114 .117
RB C 2 .94 .100 .102
B 2 1i04 .093 .091
B 4 1.09 .097 .093
R 2 .98 .099 .095
RL C2 .90 .094 o101
B 1 1.06 .089 .086
B 4 .91 .097 .102
R 2 .68 .093 .113
R 3 .85 .094 .102
JH C 2 1.14 .072 .067
B 2 .,98 .109 .110
JV C 2 .94 .091 .099
B 2 .74 .106 .123
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TABLE 1
COMPOSITE APEX CARDIOGRAPHY DATA
Subject Week of Study R-R R-dA/dt R-dA/dt
ERR
NR C 2 .99 .085 .086
B 1 .95 .120 .123
B 2 ,88 .094 .100
JG C 2 1.10 .098 .094
B 1 .91 .124 .130
B 2 .85 .122 .132
GB C 2 1.27 .107 .095
B 1 1.24 .087 .078
B 2 1.19 .085 .078
GJ C 2 1.18 .126 .116
B 2 1.16 .129 .120
RT C2 .97 .088 .089
B 2 .98 .088 .089
RV C 2 .86 .045 .049
B 2 .74 .052 .061
36
TABLE 2
CORRELATION OF R-dA/dt WITH R-R INTERVAL,
BLOOD PRESSURE, AND PLASMA VOLUME
(Control Week 2)
Subject R-dA/dt R-R Systolic BP Diastolic BP Plasma Volume
(sec) (sec) (mmHg) (mmHg) (L)
HT .060 .93 114 75 2.78
CT .080 1.01 124 76 3.40
GP .080 .72 102 74 3.47
RG .080 1.21 198 58 2.96
RR .125 .92 106 60 3.61
DJ .105 .94 110 60 3.12
CC .070 .76 110 70 2.85
JA .085 1.09 110 75 2.85
WR .100 .94 122 70 2.55
JW .048 .58 110 70 2.85
JS .080 .78 118 86 2.41
BL .097 1.13 130 54 3.17
RC .100 1.07 120 60 3.35
DY .106 1.20 136 90 3.15
RB .100 .94 120 72 3.59
RL .094 .90 112 68 3.07
JH .072 1.14 110 62 3.94
JV .091 .94 130 70 3.13
NR .085 .99 120 68 3.48
JG .098 .1.10 i12 72 2.90
GB .107 1.27 120 80 3,18
GJ .126 1.18 108 76 2.82
RT .088 .97 124 82 3.44
RV .045 .86 130 70 3.33
r 0.525 0.002 -0.033 0.074
p <0.01 <0.995 <0.9 <0.8
TABLE 3
ALTERATIONS IN QUANTITATIVE APEX CARDIOGRAPHY
INDUCED BY BEDREST
C2
R-R R-dA/dt
1.13 .097
.90 .096
.90 .094
.99 .085
1.10 .098
1.27 .107
1.05 .096
SE(95%) +,15 ±.008
R-dA/dt
.TRR
.091
.101
.101
.086
.094
.095
.095
±.004
B 
R-R R-dA/dt
.107
.097
.089
.120
.124
.087
. 104
+.015
1.16
.71
1.06
.95
.91
1.24
1.01
+,21
<0.50 <0.40 <0.40
Subject
BL
RC
RL
NR
JG
GB
Mean
R-dA/dt
ERR
.100
.115
.086
.123
.130
.078
.105
±.021
P
q8
TABLE 4
ALTERATIONS IN QUANTITATIVE APEX CARDIOGRAPHY
INDUCED BY BEDREST
C2
R-R R-dA/dt R-dA/dt
\fRR
1.13
.90
1.20
.94
1.14
.94
.99
1.10
1.27
1.18
.97
.86
1.05
.097
.096
.106
.100
.072
.091
.085
.098
.107
.126
.088
.045
.092
.091
.101
.096
.102
.067
.099
.086
.094
.095
.116
.089
.049
1.06
.63
1.23
1.04
.98
.74
.88
.85
1.19
1.16
.98
.74
.090 .96
B2
R-R R-dA/dt
.099
.095
.136
.093
.109
.106
.094
.122
.085
129
.088
.052
.100
SE(95%) ±.08 ±.011 ±.010 ±.13 ±.013
<0.02 <0.20 <0.05
Subject
BL
RC
DY
RB
JH
JV
NR
JG
GB
GJ
RT
RV
Mean
R-dA/dt
rRR
,096
.120
.123
.091
.110
123
.100
132
.078
.120
.089
.061
.104
±.012
P
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TABLE 5
ALTERATIONS IN QUANTITATIVE APEX CARDIOGRAPHY
INDUCED BY BEDREST
C2
R-R R-dA/dt
.93
1.01
.72
1.21
.92
.94
.76
1.09
.94
.58
.78
1. 13
1.07
1.20
K94
.90
.95
.060
.080
.080
.080
.125
.105
.070
.085
.100
.048
.080
.097
.100
.106
.100
.094
.088
R-dA/dt
,RR
.062
.080
.094
.073
.130
.108
.080
.083
.102
.063
.091
.091
.099
.096
.102
.101
.091
R-R
.80
.66
.60
.88
.76
.64
.81
.86
.76
.61
.74
1.03
.81
1.05
1.09
.91
.81
R-dA/dt
.070
.075
.085
.080
.135
.097
.075
.103
.091
.085
.093
.106
.120
.121
.097
.097
.097
SE(95%) ±.09 ±.010 ±.009 +.09 +.009
<0.005 <0.05 <0.001
B4
Subject
HT
CT
GP
RG
RR
DJ
CC
JA
WR
JW
JS
BL
RC
DY
RB
RL
Mean
R-dA/dt
vRR
.078
.092
.110 ·
.088
.155
.121
.083
.111
102
.104
.109
.105
.133
.118
.093
102
.106
+,010
p
I40
TABLE 6
ALTERATIONS IN QUANTITATIVE APEX CARDIOGRAPHY
INDUCED BY BEDREST
C2
R-R R-dA/dt
.92
.94
.76
1.09
.94
.58
.78
1.13
1.07
1.20
.94
.90
.94
.125
.105
.070
.085
.100
.048
.080
.097
.100
.106
.100
.094
.093
SE(95%) ±.11 ±.013
R-dA/dt
EfRR
.130
.108
.080
.083
.102
.063
.091
.091
.099
.096
.102
.101
.096
±.010
R2
R-R R-dA/dt
.65
.82
1.11
.82
.75
.65
.73
1.01
.60
.92
.98
.68
.81
.120
.110
.077
.097
.100
.055
.096
.088
.100
.118
.094
.093
.096
±.11 +±.011
<0.10 <0.20 <0.02
Subject
RR
DJ
CC
JA
WR
JW
JS
BL
RC
DY
RB
: RL
Mean
R-dA/dt
a/RR
.149
.107
.073
.107
.116
.068
.112
.088
129
o 123
.095
.113
.107
±.015
P
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TABLE 7
ALTERATIONS IN QUANTITATIVE APEX CARDIOGRAPHY
INDUCED BY BEDREST
1
1
1
1
C2
R-R R-dA/dt
.92 .125
.94 .105
.76 .070
L.09 .085
.94 .100
.58 .048
.78 .080
L.13 .097
L.07 .100
L.20 .106
.90 .094
.94 .092
SE(95%) ±.11 ±.013
R-dA/dt
ETRR
.130
.108
.080
.083
.102
.063
.091
.091
.099
.096
.101
.095
+.012
R3
R-R R-dA/dt
1.10
.78
.76
1.02
.83
·.65
.72
1.06
.98
.93
.85
.88
+.09
. 120
.095
.070
.101
.080
.050
.072
.101
.100
.114
.094
.091
±.013
<0.20 <0.40 <0.60
Subject
RR
DJ
CC
JA
WR
JW
JS
BL
RC
DY
RL
R-dA/dt
ETRR
.125
.108
.080
.100
.087
.062
.085
.098
.101
.117
.102
.097
+±010
Mean
P
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TABLE 8
ALTERATIONS IN
Week of
Study
B1
B2
B4
R2
R3
R-dA/dt INDUCED BY BEDREST
TRRP
Bedrest & Recovery
R-dA/dt
ERR
.105
±.021
.104
+.012
.106
+.010
.107
+.015
.097
o 010
P
<0.40
<0.05
<0.001
<0.02
<0.60
Subjects
Showing
Prolongation
4/6 (67%)
10/13 (77%)
14/16 (88%)
8/12. (67%)
5/11 (45%)
Control
R-dA/dt
«rRR
.095
+.004
.090
+. 010
.091
±.009
.096
+.010
.095
±.012
mA3
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TABLE 10
PLASMA VOLUME ALTERATIONS
Apex Cardiography Group
Plasma Volume (L)
Subject Control B 1
BL 3.17 3.02
RC 3.35 3.342
RL1 3.07
NR 3.48 3.47
JG 2.90 2.72
GB1 3.18
Mean 3.23 3.14
SE(95%) +.40 +.53
P 
.<.20
1Not used in calculations.
2Receiving 9-alpha-fluorohydrocortisone.
'45
TABLE 11
PLASMA VOLUME ALTERATIONS
Apex Cardiography Group.
Plasma
Control
Volume (L)
B2
3.17
3.35
3.15
3.59
3.94
3.13
3.48
2.90
3.18
2.82
3.44
3.33
2
2.81
3.13
3.52
3.28
2.60
3.25
2.68
3.03
2.67
3.32 3.00
±4.25
<0.005
1
Data not used in calculations.
2 Receiving 9-alpha-fluorohydrocortisone.
Subject
BL
1
RC1
DY
RB
JH
JV1
NR
JG
GB
GJ
RT
RV
Mean
SE(95%)
. P
46
TABLE 12
PLASMA VOLUME ALTERATIONS
Apex Cardiography Group
Plasma
Control
2.78
3.40
3.47
2.96
3.61
3.12
2.85
2.85
2.55
2.85
2.41
3.17
3.35
3.15
3.59
3.07
3.11
+.20
Volume (L)
B4
2.70
3.14
2.93
2.91
3.04
2.88
2.49
2
2.692
2.902
3.00
3.392
2.70
3.22
2.892
2.92
±+.14
<0.05
1Not used in calculations.
2 Receiving 9-alpha-fluorohydrocortisone.
Subject
HT
CT
GP
RG
RR
DJ1
CC
JA
,WR1
JW
JS
BL
RC
DY
RB
RL
Mean
SE(95%)
P
L7
TABLE 13
PLASMA VOLUME ALTERATIONS
Apex Cardiography Group
Plasma Volume (L)
Subject Control R 2
RR 3.61 3.43
DJ 3.12 3.19
CC 2.85 3.56
JA 2.85 2.91
WR 2.55 2.45
JW 2.85 3.07
JS 2.41 2.98
BL 3.17 3.40
RC 3.35 3.62
DY 3.15 3.40
RB 3.59 3.36
RL 3.07 3.26
Mean 3.05 3.22
SE(95%) +±.23 ±.21
<0.10P
L7.S
TABLE 14
PLASMA VOLUME - APEX CARDIOGRAPHY GROUP
(Liters - Mean ±SE 95%)
Control
Plasma Volume
3.23
+.40
3.32
±.27
3.11
+.20
Week of Study
B1
B2
B4
R23.05
+.23
Bedrest & Recovery
Plasma Volume
3.14
+.53
3.00
+.25
2.92
+. 14
3.22
+.21
P
<0.20
<.005
<.05
<.10
a9
TABLE 15
CORRELATION BETWEEN R-dA/d AND PLASMA VOLUME ALTERATIONS
A R-dA/dt
JR-R
.009
.014
-.015
.027
.036
-.017
Bedrest Week 1
A Plasma Volume
-.15 i
-.01
-.01
-.18
-0.22
<0.80
1Data not used in calculations.
Subject
IBL
RC
RL1
NR
JG
GB1
r
p
50
TABLE 16
CORRELATION BETWEEN R-dA/dt AND PLASMA VOLUME ALTERATIONS
,JR-R
Bedrest Week 2
A Plasma Volume
-.34
-.46
-.42
-.20
-.30
.07
-.14
-.41
-.66
-0.32
<0.40
1Data not used in calculations.
Subject
BL1
RC1
DY
RB
JH
JVI
NR
JG
GB
GJ
RT
RV
R-dA/dt
JTR-R
.005
.019
.027
-.011
.043
.024
.014
.038
-.017
.004
.000
.012
r
P
51
TABLE 17
R-dA/dtCORRELATION BETWEEN R-dt AND PLASMA VOLUME ALTERATIONS
BedR-Rest Week 4
Bedrest Week 4
A R-dA/dt
,-R-R
.016
.012
.016
.015
.025
.015
.003
.028
.000
.041
.018
.014
.034
.022
-.009
-.001
A Plasma Volume
-.08
-.26
-.54
-.05
-.55
.03
-.36
-.16
.49
-.17
-.04
-.45
-.37
-.18
-0.01
<0.98
1Data not used in calculations.
Subject
HT
CT
GP
RC
RR
DJ1
CC
JA
WR1
JW
JS
BL
RC
DY
RB
RL
r
P
TABLE 18
CORRELATION BETWEEN R-dA/dt AND PLASMA VOLUME ALTERATIONS
r-R-R
Recovery Week 2
Subject A R-dA/dt A Plasma Volume
J-R I
RR .019 -. 18
DJ -. 001 .05
CC -. 007 .71
JA .024 .06
WR .014 -.10
JW .005 .22
JS .021 .57
BL -.003 .23
RC .030 .27
DY .027 .25
RB -.007 -.23
RL .012 .19
r -0.001
P <0.99
53
TABLE 19
COMPOSITE SYSTOLIC TIME INTERVAL DATA
Week ofSubject Study
Study
C2
B4
R2
R3
C2
B4
R2
R3
JS
BL
C2
B4
R2
R3
C2
B1
B2
B4
R2
R3
R-R Q-S2 Q-S2I
.83
.85
1.00
.81
1.15
.96
.85
1.01
.79
.79
.76
.69
1.13
1.16
1.06
1.08
1.01
1.06
.370
.394
.431
.386
.463
.430
.427
.442
.355
.382
.372
.372
.379
'o395
.373
.374
.373
.384
.521
.541
.557
.541
.572-
.562
.575
.566
.515
.542
.538
.555
.490
.507
.491
.490
.499
.502
LVET LVETI
.282
.292
.326
.289
.342
.310
.306
.320
.275
.289
.285
.285
.302
.314
.297
.292
.302
.305
.405
.412
.428
.414
.431
.416
.426
.422
.403
.417
.419
.432
.392
.402
.393
.386
.404
.401
PEP
PEP PEPI LVET
.089
.102
·105
.097
·121
.120
·121
o 122
.080
.097
.087
.087
.077
.084
.076
.082
.071
.079
.118
.130
.129
· 122
142
· 145
149
.146
.110
.127
.119
.122
.098
.105
.099
.104
.095
.101
.317
.350
.322
.336
.354
.387
.395
.381
.291
.336
.305
.305
.255
.268
.256
.281
.235
.259
.88 .385
.73 .351
.61 .309
1.20
1.23
1.05
.95
.93
1.04
1.09
,98
.90
1.06
.93
.68
.85
.409
.425
.409
.411
.420
.424
.437
.438
.381
.413
.403
.374
.392
1.38 .463
1.08 .433
.553 .346
.551 .325
.420 .117 .134 .338
.420 .108 .130 .332
C2
B 1
B2
RC'
DY
RB
C2
B2
B4
R2
C2
B2
B4
R2
C2
B 1
B4
R2
R3
RL
.528
.523
.515
.514
.548
.529
.543
.554
.545
.552
.567
.522
.531
.537
.561
.540
.290
.258
.228
.325
.318
.306
°300
.298
.299
.313
.306
.293
.305
.297
.275
.289
.406
.402
.395
.410
.401
.404
.408
.407
.395
.406
.411
.407
.401
.409
.421
.409
.094
.093
.081
.084
.107
.103
.111
.123
·125
.124
.132
.088
.108
106
.099
.103
· 121
.126
120
· 104
.127
.126
.136
.149
·148
.146
157
.115
131
.135
.135
131
.324
.360
.355
.259
.336
.337
.370
.412
.418
.396
.431
.300
.354
.357
.360
.356
B2
CC
JA
JH
5F4
TABLE 19
COMPOSITE SYSTOLIC TIME INTERVAL DATA
Week of
Subject Study
Study
JV C2
B1
B2
B4
R-R Q-S2 Q-S2I
.89
.76
.88
.64
.387
.348
.373
.320
.528
.514
.517
.516
LVET LVETI
.288
.248
.272
.238
.402
.382
.410
.396
PEPPEP PEPI ELVET
.099
.100
.101
.082
.126
.132
.128
.119
.344
.403
.371
.345
.99 .403
.98 .391
.88 .372
1.10
.92
.85
1.27
1.24
1. 19
1.28
1.41
1.53
.86
.74
.77
.83
1.18
1.16
.97
1.08
.411
.356
.362
.445
.426
.436
.421
.436
.449
.412
.385
.401
.432
.444
.415
.388
.423
.86 .409
.97 .417
.89 .389
°74 .368
.91 .372
1.01 .387
1.26 .432
1.16 .418
.556 .307
.547 .308
.520 .287
.537. .266
.510 .287
.513 .280
.532 .322
.526 .326
.426 .103 .131 .335
.412 .109 .134 .354
.401 .102 .129 .356
.403 .102 .134 .386
.399 .085 .111
.387 .107 .131
.296
.382
.404 .110 .129 .343
.413 .092 .113 .282
NR C2
B1
B2
JG C2
B1
B2
GB
JP
C2
B1
B2
C2
B1
B2
.530
.519
.515
.526
0493
.510
.543
.526
.542
.519
.524
.531
.559
.556
.567
.584
.551
.524
.519
.539
.308
.283
.279
.322
.269
.263
.327
.310
.301
.320
.329
343
.303
.275
.280
.304
.324
.325
.287
.315
JB
GJ
.411
.390
.395
.415
.381
.383
.407
.393
.387
.400
.401
.410
.421
.413
.413
.427
.411
.413
.393
.409
.095
.108
.093
.089
.087
.099
.118
.116
.135
.101
.107
.106
.109
.110
O 121
.128
120
.090
.101
.o 108
.119
.133
·120
.111
*113
127
· 137
135
.155
120
.124
o122
.137
.142
O 152
157
.140
.111
· 126
.130
C2
B4
R2
R3
C2
B2
B4
R2
.308
.381
.333
.279
.323
.376
.360
.374
.449
.316
.325
.309
.360
.400
.401
.421
.369
.277
.352
.343
RT
RV
LC
AM
C. 2
B2
C2
B2
C2
B2
C2
B2
55
TABLE 20
CORRELATION OF PEP/LVET WITH R-R INTERVAL,
BLOOD PRESSURE, AND PLASMA VOLUME
(Control Week 2)
Systolic BP
(mmHg)
110
110
118
130
110
136
120
112
110
130
120
112
120
116
115
108
124
130
124
114
-0.290
<0.3
Diastolic
(mmHg)
BP
70
75
86
54
60
90
72
68
62
70
68
72
80
78
75
76
82
70
84
74
-0.012
<0.975
Plasma Volume
(L)
2.85
2.85
2.41
3.17
4.03
3.15
3.59
3.07
3.94
3.13
3.48
2.90
3.18.
3.65
3.27
2.82
3.44
3.33
2.71
2.82
0.239
<0.4
Subject
CC
JA
JS
BL
RC'
DY
RB
RL
JH
JV
NR
JG
GB
JP
JB
GJ
RT
RV
LC
AM
PEP/LVET
.317
.354
.291
.255
.324
.259
.412
.300
.338
.344
.308
.279
.360
.316
.360
.369
.335
.356
.296
.343
R-R
(sec)
.83
1.15
.79
1.13
.88
1.20
.93
.90
1.38
.89
.99
1.10
1.27
1.28
.86
1.18
.86
.89
.91
1.26
-0. 019
<0.95
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TABLE 26
ALTERATIONS IN PEP/LVET
INDUCED BY BEDREST
Control Week of
PEP/LVET Study
.311
+.028
B1
Bedrest & Recovery
PEP/LVET
.349
±.035
P
<0.0025
Subjects
Showing
Increase
8/8 (100%)
11/15 (73%)
9/10 (90%)
7/9 (78%)
6/6 (100%)
B2 .348
±.030
B4
.326
+.024
.326
+± 036
.324
+.041
.313
±.041
.354
+.025
R2
<0.10
<0.02
<0.10
<0.025
.351
±.045
R3 .343
±.059
62
TABLE 27
PLASMA VOLUME ALTERATIONS
STI Group
Plasma Volume
Control
3.17
4.03
3.07
3.13
3.48
2.90
3.18
3.65
3.39
+.43
1Not used in calculations.
Subject
BL
RC'
RL1
JV
NR
JG
GB1
JP
(L)
B1
3.02
4.02
3.06
3.47
. 2.72
Mean
SE(95%)
P
3.31
3,27
+.47
<0.10
TABLE 28
PLASMA VOLUME ALTERATIONS
STI Group
Subject
BL
RC' 1
DY
RB
JH
JV1
NR
JG
GB
JP
GJ
RT
RV
LC
AM
Mean
SE(95%)
P
1Not used in calculations.
Plasma
Control
3.17
4..03
3.15
3.59
3.94
3.13
3.48
2.90
3.18
3.65
2.82
3.44
3.33
2.71
2.82
' 3.25
+.25
Volume (L)
B2
2.81
3.13
3.52
3.28
2.60
3.25
3.47
2.68
3.03
2.67
2.62
2.70
2.98
+.22
<0.001
.,
f;4
TABLE 29
PLASMA VOLUME ALTERATIONS
STI Group
Plasma Volume (L)
Subject Control B 4
CC 2.85 2.88
JA 2.85 2.49
JS 2.41 2.901
BL 3.17 3.00
DY 3.15 2.70
RB 3°59 3.22
RL 3.07 2.89
JV 3.13 3.15
JB 3.27 3.271
GJ 2.82 2.64
Mean 3.03 2.91
SE(95%) +.23 ±.18
P <0,20
1Receiving 9-alpha-f liorohydrocortisone.
I5
TABLE 30
PLASMA VOLUME ALTERATIONS
STI Group
Plasma Volume (L)
Subject Control R 2
CC 2.85 3.56
JA 2.85 2.91
JS 2.41 2.98
BL 3.17 3.40
DY 3.15 3.40
RB 3.59 3.36
RL 3.07 3.26
JB 3.27 3.15
GJ 2.82 2.72
Mean 3.02 3.19
SE(95%) +±.26 +.21
<0.20P
gf6
TABLE 31
PLASMA VOLUME - STI GROUP
(Liters - Mean ±SE 95%)
Control
Plasma Volume
3.39
±.43
3.25
±.25
3.03
+.23
3.02
±.26
Week of Study
B1
B2
B4
R2
Bedrest & Recovery
Plasma Volume
3.27
±+.47
2.98
±.22
2.91
±+18
3.19'
+.21
P
<0.10
<.0001
<.20
<.20
i .
67
TABLE 32
CORRELATION BETWEEN PEP/LVET AND PLASMA VOLUME ALTERATIONS
Bedrest Week 1
Subject A PEP/LVET .A Plasma Volume
BL .013 -.15
RC' -036 -.01
RL1 .054
JV .059 -.07
NR .073 -.01
JG .044 -.18
GB1 .014
JP .009 -.34
r 0.12
P <0.90
1Data not used in calculations,
TABLE 33
CORRELATION BETWEEN PEP/LVET AND PLASMA VOLUME ALTERATIONS
Bedrest Week 2
Subject A PEP/LVET A Plasma Volume
BL1 .001
RC' 1 .028
DY .077 
-.34
RB .006 
-.46
JH 
-.006 
-.42
JV1 .027
NR .025 
-.20
JG .097 
-.30
GB .089 .07
JP 
-.007 
-.18
GJ 
-.092 
-.14
RT .019 
-.41
RV .030 
-.66
T,V t086 
-.09
AM 
-. 060 
-.12
r 0.02
P <0.95
not used in calculations.1DataData
I9
TABLE 34
CORRELATION BETWEEN PEP/LVET AND PLASMA VOLUME ALTERATIONS
Bedrest Week 4
Subject A PEP/LVET A Plasma Volume
CC .033 .03
JA .033 -.36
JS .045 .49
BL .026 -.17
DY .078 -.45
RB -.017 -.37
RL .057 -.18
JV .001 -.02
JB -.040 .00
GJ -.017 -.18
r -0,06
P <0.90
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TABLE 35
CORRELATION BETWEEN PEP/LVET AND PLASMA VOLUME ALTERATIONS
Recovery Week 2
Subject /A PEP/LVET A Plasma Volume
CC .005 .71
JA .041 .06 
JS .014 .57
BL -.020 .23
DY .011 .25
RB .019 -.23
RL .060 .19
JB .041 -.12
GJ -.026 -.10
r -0.12
P <0.80
TABLE 36
ECHOCARDIOGRAPHY
General Data - Cardiac Catheterization Group
Subject Age Diagnosis
MM 47 Mitral stenosis, mild aortic regurgitation.
EC 64 Moderate mitral stenosis and severe mitral regurgitation.
CN 46 Severe cardiomyopathy.
CM 52 Moderate aortic regurgitation.
EK 31 Moderate mitral regurgitation.
JG 20 Asymptomatic murmur.
AM 44 Severe mitral stenosis, aortic regurgitation.
CR 56 Coronary artery disease.
DH 55 Severe mitral stenosis.
EW 68 ? IoH.S.S., cardiomyopathy.
DJ 46 Coronary artery disease.
HM 46 After aneurysm removal.
JA 68 Severe mitral regurgitation, tricuspid regurgitation.
FV 29 Moderate mitral regurgitation.
JS 43 Coronary artery disease.
AC 26 Severe mitral stenosis.
LK 67 Radiation peri-myocarditis.
FC 47 Coronary artery disease.
HV 60 Coronary artery disease.
RL 48 Mild mitral regurgitation, ? cardiomyopathy.
BH 62 Cardiomyopathy.
Mean 48.8
72
TABLE 37
Cardiac Catheterization Group
Values of Echocardiographic Parameters and Intravascularly
Obtained Indices of Left Ventricular Function
Heart PWV PWE PWV x PWE Maximum PCV LVEDP
Subject Rate cm/sec cm cm2 !sec LV dP/dt mmHg mmHg
70
80
84
68
90
74
81
62
92
54
86
84
96
72
80
94
98
75
80
118
74
3.23
2.71
1.41
2.50
2.06
2.77
2.07
3.03
1.49
1.93
2.58
2.57
4.34
2.71
2.21
2.29
1.95
2.33
1.63
1.84
0.94
0.93
0.81
0.45
0.60
0.44
0.62
0.39
0.82
0.27
0.57
0.64
0.74
1.58
0.70
0.60
0.62
0.58
0.54
0.21
0.17
0.27
3.02
2.19
0. 64
1.50
0.91
1.72
0.81
2.48
0.40
1.10
1.66
1.90
6.84
1 ;89
1.63
1.40
1.12
1.20
1.43
1.34
1,23
1160
1850
1080
1750
1400
1260
1810
1720
2260
1650
2080
2750
2640
2950
1410
1350
1560
17
20
11
16
18
11
25
11
11
10
10
7
18
10
8
25
20
16
10
33
28
EDV EF Fick C.O.
ml % L/min
12 191
24 172
20 405
22 328
20 322
163
16 3.4
10 105
12 111
18 345
9 141
7 224
13 205
8 158
6 146
5 94
22 114
16 277
235
45 229
20 268
77 4.32
68 3.40
19 2.70
67 7.60
76 6.80
86 8.87
27 3.49
62 ' 5.85
3.90
25 3.18
76 5.93
60 5.61
81 A4.03
81 3.85
70 4.86
4.12
45 4.50
24 5.66
47 5.78
16 2.19
19 2.49
81.5 2.31 0.60 1.59 16 16 217 60 4.53
MM
EC
CN
CM
EK
JG
AM
CR
DH
EW
DJ
HM
JA
F1'
JS
AC
LK
FC
HV
RL
BH
Mean
I
i
1704
73
TABLE 37
Cardiac Catheterization Group
Values of Echocardiographic Parameters and Intravascularly
Obtained Indices of Left Ventricular Function
Angio
Subject C.O.
L/min
Fick
C.I.
L/mm/BSA
S.V.
Fick
ml
S.V.
Angio
ml
V
max
Circum/sec
LVET ICT
sec sec
7.26 2.66
9.30 2.00
6.80 1.50
14.60 3.50
16.50 3.80
9.30 4.62
7.05 2.42
10.20 3.05
7.74 2.30
5.26 1.98
3.43
3.05
2.40
2.25
2.66
i.32 2.78
8.90 2.52
3.14
9.60 3.32
1.39
1.34
64 165
42 117
24 76
115 221
87 251
110 140
55 87
100 171
49 90
66 86
107
66 135
45 168
56 128
73 1J0
87 -77
47 - 89
80 69
73 128
18 36
26 52
1.78
1.99
1.20
1.65
1.37
1.58
1.38
1.23
1.93
1.31
1.61
1.63
2.34
1.95
1.20
1.34
1.23
0.380
0.320
0.260
0.280
0.285
0.250
0.315
0.290
0.330
0.295
0.320
0.270
0.280
0.310
0.320
0.270
0.280
0.210
0.230
0.095
0.065
0.160
0.070
0.065
0.180
0.120
0. 120
0.120
0.080
0.100
0.096
0.110
0.095
0.090
0.095
0.130
0.140
0.100
21 0.124
23 0.096
15 0.170
18 0.102
16 0.142
34
18
19
6
10
16
11
15
23
21
24
17
0.126
0.136
0.124
0.120
0.118
0.116
0.140
0.li2
0.108
0.112
0.130
12 0.114
15 0.124
0.290 0.107 17.6 0.123
Tension
Time
Index
R-dP/dt
sec
EC
CN
CM
EK
JG
AM
CR
DIt
EW
DJ
HM
JA
FV
JS
AC
LK
FC
HV
RL
BHl
Mean 6.42 2.07 64 120 1.48
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TABLE 38
Cardiac Catheterization Group
Echocardiographic Parameters - Summarized Correlation
Coefficients and Significance Levels
Max LV dP/dt 
-.05
PCV 
-.12
LVEDP 
-.26
EDV 
-.32
EF .74
Fick C.O. .30
Angio C.O. .16
Fick C.I. .34
S.V. Fick .32
S.V. Angio -.24
V .19
max
LVET .43
ICT 
-.31
Tension Time Index -.07
R-dP/dt 
-.25
PWV
P
NS
NS
NS
NS
<.001
NS
NS
NS
NS
NS
NS
<.10
NS
NS
NS
-r
.02
.20
-.41
-.24
.65
-. 10
o13
.14
.42
.19
.49
-.46
-.13
-.26
PWE
P
NS
NS
<.10
NS
<.05
NS
NS
NS
NS
<.05
NS
<.05
<.05
NS
NS
PWV x
r
.06
-.14
-.30
-.22
.61
.14
.40
-.02
.20
-.31
.44
PWE
P
NS
NS
NS
NS
<.05
NS
NS
NS
NS
<.10
NS
NS
NS
NS
<.1
TABLE 39
Cardiac Catheterization Group
Echocardiographic Parameters: Correlations With Ejection
Fraction in Patients With and Without Coronary Artery Disease
PWV PWE PWV x PWE
cm/sec cm cm2 /sec
Patients Without r .83 .73 .62
Coronary Disease P <.001 <.001 <.01
n = 14
Patients With r .32 .41 .53
Coronary Disease
5nP NS NS NSn = 5
TABLE 40
ECHOCARDIOGRAPHY - BEDREST GROUP
Posterior Wall Velocity
(cm/sec)
Week of
C1 C2 B2
1.29
3.55
1.74
2.42
1.99
1.22
3.21
3.32
2.76
2.45
2.34
2023
4.30
2.15
2.94
2.29
2.95
3.45
3.22
3.24
1.85
4.40
3.18
2.95
Study
B4 R1 R2
1.86
1.90
2.26
2.06
2.10
3.54
4.38
3.42
2.74
1.33
3.07
2.66
2.88
2.37
2.61
1.57
2.33
2.65
2.68
2.66
1.70
1.72
3.67
Subject
RC
DY
RB
JV
GB
JP
GJ
RT
LC
AM
TABLE 41
ECHOCARDIOGRAPHY - BEDREST GROUP
Posterior Wall Excursion
(cm)
Week
C2 B2
.61
.63
.54
054
1.40
.51
054
.49
.64
.75
.83
.74
.50
1.23
.55
.77
of Study
B4
.55
.44
.65
.63
.72
.86
.92
R1 R2
.37
.56
.31
.53
.67
.78
.68
.46
.73
.45
.47
.55
.53
.47
.47
.83
C1
.39
.89
.51
.56
.47
.41
Subject
RC
DY
RB
JV
GB
JP
GJ
RT
LC
AM
.76
.99
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FIGURES
1. Illustration of Measurements of R-dA/dt and Systolic Time
Intervals.
2. Correlation of R-dA/dt and R-R Interval.
3. Alterations in R-dA/dt/ JR-R Induced by Bedrest.
4. Plasma Volume Changes - Apexcardiography Group.
5. Alterations in PEPI, LVETI and Q-S2I Induced by Bedrest.
6. Alterations in PEP/LVET Induced by Bedrest.
7. Plasma Volume Changes - STI Group.
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FIGURE 2
CORRELATION OF R- dA/dt VS. R-R INTERVAL
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FIGURE 3
ALTFRATIONS IN (R-dA/dt)/R-R INDUCED BY BEDREST
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FIGURE 4
APEXCARDIOGRAM GROUP
PLASMA VOLUME: BEDREST-INDUCED CHANGES
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FIGURE 5
!
I
ALTERATIONS IN SYSTOLIC TIME INTERVALS
INDUCED BY BEDREST
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FIGURE 6
ALTERATIONS IN PEP/LVET INDUCED BY BEDREST
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FIGURE 7
SYSTOLIC TIME INTERVALS GROUP
PLASMA VOLUME: BEDREST-INDUCED CHANGES
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